510(k) Report

510(k) · Cleared

Cleared

BonOs HV Genta, BonOs MV Genta, BonOs LV Genta

K210125510(k) TraditionalCleared Mar 19, 202159-day reviewClass II21 CFR 888.3027

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Osartis GmbH · LOD Bone Cement

Cleared on Mar 19, 2021 as substantially equivalent to K143100 (Cossington, Ltd., 2015) and 1 other predicate after a 59-day review. Its family tree reaches back 5 generations to 2001.

Decided
Mar 19, 2021
Review
59 days
Class
Class II
Product code
LOD
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K000943 (2001). 7 ancestors in all, the oldest P810020 (1984). No later device cites it as a predicate yet.

  1. Root · 5 generations backK000943 Cemex System Gun Application VersionExactech, Inc. · 2001
  2. 4 generations backK033596 Cemex Genta Bone Cement; Cemex Genta System Bone CementExactech, Inc. · 2004
  3. 3 generations backK043403 Cemex System Genta Fast Bone CementExactech, Inc. · 2004
  4. 2 generations backK092773 Cemex Genta, Genta System and Genta System FastTecres S.P.A. · 2009
  5. 1 generation backK143100 NP Cement HV Genta;NP Cement LV Genta;NP Cement HV System Genta;NP…Cossington, Ltd. · 2015
  6. This deviceK210125 BonOs HV Genta, BonOs MV Genta, BonOs LV GentaOsartis GmbH · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K000943Cemex System Gun Application VersionExactech, Inc.2001—
−4K033596Cemex Genta Bone Cement; Cemex Genta System Bone CementExactech, Inc.2004—
−3K043403Cemex System Genta Fast Bone CementExactech, Inc.2004—
−2K092773Cemex Genta, Genta System and Genta System FastTecres S.P.A.2009—
−1K143100NP Cement HV Genta;NP Cement LV Genta;NP Cement HV System Genta;NP Cement LV…Cossington, Ltd.2015—
0 (this device)K210125BonOs HV Genta, BonOs MV Genta, BonOs LV GentaOsartis GmbH2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198410
200410
FIG. 1 — Lineage of K210125, 2001–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LOD device

  1. #1 K254107 Refobacin Bone Cement R (110034355)score 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143100NP Cement HV Genta;NP Cement LV Genta;NP Cement HV System Genta;NP Cement LV System Genta
Summary page 5
…ntibiotics Panel: Orthopedic 3. Predicate Device The predicate devices are as follows: - Rally™ HV AB Bone Cement (510(k) application K143100) - Palacos® R+G (510(k) application K031673) 4. Device Description BonOs® HV Genta, BonOs® MV Genta and BonOs® LV Genta…
Cossington, Ltd.2015—
*K031673Refobacin -Palacos G
Summary page 5
…edic 3. Predicate Device The predicate devices are as follows: - Rally™ HV AB Bone Cement (510(k) application K143100) - Palacos® R+G (510(k) application K031673) 4. Device Description BonOs® HV Genta, BonOs® MV Genta and BonOs® LV Genta are PMMA, radiopaque bone cements, containing ge…
Heraeus Kulzer GmbH & Co. KG20041

Also cleared against K143100: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 4.9 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K143100.

How does its category compare?

All LOD devices

LOD Bone Cement: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LOD

1in 2025

2007: 22008: 12009: 32013: 22014: 12015: 42016: 12017: 32018: 22019: 42020: 32021: 42022: 32023: 22024: 12025: 12026 (partial year): 1
2007high 4 (2015) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LOD

277in 2022

2009: 103 days median2015: 138 days median2017: 96 days median2019: 90 days median2020: 139 days median2021: 95 days median2022: 277 days median
2007high 277 (2022) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LOD

2in 2022

2014: 12017: 42020: 12022: 22026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LOD

355in 2025

2007: 782008: 1342009: 1702010: 2912011: 4282012: 4122013: 5012014: 4652015: 5292016: 6152017: 8172018: 1,2952019: 2,3072020: 1,2942021: 7822022: 4722023: 4752024: 4922025: 355
2007high 2,307 (2019) · low 78 (2007)2025

MAUDE reports naming product code LOD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—078
20081—0134
200931030170
20100—0291
20110—0428
20120—0412
20132—0501
20141—1465
201541380529
20161—0615
20173964817
20182—01,295
201949002,307
2020313911,294
20214950782
202232772472
20232—0475
20241—0492
20251—0355
20261—2—

What is it indicated for?

BonOs® HV Genta, BonOs® MV Genta and BonOs® LV Genta are intended for the fixation of prothesis to living bone in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K210125: BonOs HV Genta, BonOs MV Genta, BonOs LV Genta.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210125

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026